Arbor Biotechnologies
Genetic medicines for genetic diseases
103 employees · est. 2016 · Cambridge, United States
GenEdit
Delivering the potential of genetic medicines
47 employees · est. 2016 · South San Francisco, United...
Arbor Biotechnologies is the larger of the two.
Side-by-Side Comparison
| Metric | Arbor Biotechnologies | GenEdit |
|---|---|---|
| Founded | ||
| Founded | 2016 | 2016 |
| Headquarters | ||
| Headquarters | Cambridge, United States | South San Francisco, United States |
| Employees | ||
| Employees | 103 larger | 47 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Life Sciences | Biotechnology, Health and Wellness, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Unknown | Series A |
| Total Funding | ||
| Total Funding | $304.50M | $67.73M |
| Funding Rounds | ||
| Funding Rounds | 5 | 7 |
| Services | ||
| Services | Developing novel gene editing treatments, Providing a diversified editing toolbox, Pioneering next-generation gene therapies, Conducting clinical trials for genetic diseases | Development of Precision Genetic Medicines, Targeted Delivery of Genetic Payloads, Restoration of Immune Balance, Pipeline for Autoimmune and Oncology Therapies |
| Target Customers | ||
| Target Customers | Patients living with genetic diseases, Healthcare providers seeking genetic solutions, Biotechnology investors and partners, Scientific and medical researchers | Patients with Autoimmune Diseases, Healthcare Providers, Biotechnology Researchers, Pharmaceutical Companies |
| Taxonomy | ||
| Taxonomy | Genetic Medicines, Gene Editing, Genomic Editors, Disease Pathology, Diagnostic Development, Genome Sequencing, Gene Synthesis, High-Throughput Screening, Bio-Discovery, CRISPR, Bioengineering, Protein Discovery, Molecular Biology | Genetic Medicines, Gene Therapy Delivery, Polymer Nanoparticles, Non-Viral Gene Editing, Therapeutic Candidates, NanoGalaxy Platform, Target Tissue Delivery, Gene Therapy Innovation, Non-Lipid Nanoparticles, Therapeutic Gene Editing, High Unmet Medical Need, Iterative Screening Process, Non-Viral Therapeutics, Genetic Disease Treatment, Safer Gene Editing |
| Website | ||
| Website | arbor.bio | genedit.com |
About Arbor Biotechnologies
Arbor Biotechnologies, founded in 2016, is at the forefront of the Biopharma, Biotechnology, and Life Sciences industries. Based in the United States, this next-generation gene editing company aims to tackle genetic diseases with its slogan, "Genetic medicines for genetic diseases." The company sta...
About GenEdit
GenEdit, a biotechnology startup founded in 2016 and headquartered in the United States, is pioneering solutions in the realm of genetic medicines with its innovative slogan: "Delivering the potential of genetic medicines". The company addresses a critical bottleneck in the field—effective delivery...
We will tell you when either one moves
BounceWatch watches Arbor Biotechnologies and GenEdit for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Arbor Biotechnologies and GenEdit — by email.
Frequently Asked Questions
Compare Arbor Biotechnologies with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Arbor Biotechnologies on 15 Jun 2026, and GenEdit on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.